Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1984 1
1990 1
2003 1
2005 1
2007 3
2008 2
2009 2
2010 1
2013 2
2014 4
2015 4
2016 2
2017 2
2018 2
2019 5
2020 4
2021 5
2022 4
2023 9
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liver.
Gruevska A, Leslie J, Perpiñán E, Maude H, Collins AL, Johnson S, Evangelista L, Sabey E, French J, White S, Moir J, Robinson SM, Alrawashdeh W, Thakkar R, Forlano R, Manousou P, Goldin R, Carling D, Hoare M, Thursz M, Mann DA, Cebola I, Posma JM, Safinia N, Oakley F, Hall Z. Gruevska A, et al. Among authors: forlano r. Metabolism. 2025 Jul;168:156237. doi: 10.1016/j.metabol.2025.156237. Epub 2025 Mar 22. Metabolism. 2025. PMID: 40127860 Free article.
Screening for NAFLD-Current Knowledge and Challenges.
Forlano R, Sigon G, Mullish BH, Yee M, Manousou P. Forlano R, et al. Metabolites. 2023 Apr 9;13(4):536. doi: 10.3390/metabo13040536. Metabolites. 2023. PMID: 37110194 Free PMC article. Review.
Another arrow in the NASH quiver?
Forlano R, Manousou P. Forlano R, et al. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):96-97. doi: 10.1016/S2468-1253(22)00383-1. Epub 2022 Dec 12. Lancet Gastroenterol Hepatol. 2023. PMID: 36521502 No abstract available.
Non-Alcoholic Fatty Liver Disease and Vascular Disease.
Forlano R, Mullish BH, Nathwani R, Dhar A, Thursz MR, Manousou P. Forlano R, et al. Curr Vasc Pharmacol. 2021;19(3):269-279. doi: 10.2174/1570161118666200318103001. Curr Vasc Pharmacol. 2021. PMID: 32188385 Review.
Detection of senescence using machine learning algorithms based on nuclear features.
Duran I, Pombo J, Sun B, Gallage S, Kudo H, McHugh D, Bousset L, Barragan Avila JE, Forlano R, Manousou P, Heikenwalder M, Withers DJ, Vernia S, Goldin RD, Gil J. Duran I, et al. Among authors: forlano r. Nat Commun. 2024 Feb 3;15(1):1041. doi: 10.1038/s41467-024-45421-w. Nat Commun. 2024. PMID: 38310113 Free PMC article.
Non-alcoholic fatty liver disease and cardiovascular risk: an update.
Mullish BH, Forlano R, Manousou P, Mikhailidis DP. Mullish BH, et al. Among authors: forlano r. Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1175-1177. doi: 10.1080/17474124.2018.1533117. Epub 2018 Oct 16. Expert Rev Gastroenterol Hepatol. 2018. PMID: 30791787 Free article. No abstract available.
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B.
Kalafateli M, Forlano R, Barnes E, Martinez-Gili L, Lacey M, Sigon G, Mullish BH, Mallet V, Parlati L, Richardson P, Forde N, Serviddio G, Villani R, Lens S, Buti M, Vargas E, Viganò M, Loglio A, Lampertico P, D'ambrosio R, Monico S, Maffi G, Lombardi R, Fracanzani AL, De Luca C, Ingiliz P, Mangia A, Leserre F, Napolitano AM, Piazzolla V, Russo FP, Raimondo G, Cacciola I, Saitta C, Lemoine M, Papatheodoridis G, Papatheodoridi M, Samonakis DN, O'Donnell D, O'Donoghue J, Abeles RD, Pugliese N, Aghemo A, Berenguer M, Brown A, Thursz MR, Manousou P. Kalafateli M, et al. Among authors: forlano r. Clin Gastroenterol Hepatol. 2025 Jul 2:S1542-3565(25)00533-6. doi: 10.1016/j.cgh.2025.06.014. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 40609817 Free article.
Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD.
Colosimo S, Miller H, Koutoukidis DA, Marjot T, Tan GD, Harman DJ, Aithal GP, Manousou P, Forlano R, Parker R, Sheridan DA, Newsome PN, Alazawi W, Cobbold JF, Tomlinson JW. Colosimo S, et al. Among authors: forlano r. Diabetes Res Clin Pract. 2024 Nov;217:111820. doi: 10.1016/j.diabres.2024.111820. Epub 2024 Aug 13. Diabetes Res Clin Pract. 2024. PMID: 39147101
57 results